Pathology





Blood Test for Receptor Predicts Prostate Cancer Treatment Response
Prostate cancer patients whose tumors contain a shortened receptor called androgen-receptor splice variant 7 messenger ribonucleic acid are less likely to respond to two widely used drugs for metastatic prostate cancer. More...21 Sep 2014

In Other News
Large Genetic Study Identifies New Prostate Cancer Loci
New Gene Mutations Found for Wilms Tumor
APOE Genotype Biomarkers Evaluated for Alzheimer Disease
Novel Method Developed for More Effective Noninvasive Prostate Cancer Screening
Flow Cytometry Assay Speeds Diagnosis of Pediatric Tuberculosis
Sound Waves Separate Tumor and Blood Cells
Biomarker Identifies Breast Cancers with Poor Prognoses
Blood Test May Revolutionize Brain Cancer Diagnosis
Cervical Cancer Screening Test Receives Approval for the European Sector
Bladder Cancer Risk Predicted by Low Levels of Blood in the Urine
US FDA Approves Noninvasive DNA Colorectal Cancer Screening Test
Gene Identified That Promotes Childhood Cancers
Microfluidic Device Monitors Key Step in Development of Tumor Metastases
New Partnership Designed to Automate Dystrophin Measurement
Biomarker for an Aggressive Breast Cancer Identified
Biomarker Identified for Head and Neck Cancers
Pathologists Publish Recommendations for Prostate Cancer Active Surveillance
New Gene Tied to Major Breast Cancer Risk
Effective Prognostic Marker Identified for Ovarian Cancer
Modern Methods Accurately Detect Cervical Cancer
Multigene Assay Predicts Cancer Patient's Survival
Combined Spectroscopy System Rapidly Scans Skin Lesions for Cancer Signs
Composition of the Gut Microbiome Differentiates Normal Individuals from Those with Precancerous Polyps or Invasive Colorectal Cancer
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.